RNA · Categories · Form 4
RNA - SEC Form 4 insider transactions
Atrium Therapeutics Inc. (RNA) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for RNA
- SEC Form 4 filed by Kenney Stephanie4 - Atrium Therapeutics, Inc. (0002093101) (Issuer)
- SEC Form 4 filed by Hughes Steven George4 - Atrium Therapeutics, Inc. (0002093101) (Issuer)
- SEC Form 4 filed by Winslow Brendan R.4 - Atrium Therapeutics, Inc. (0002093101) (Issuer)
- SEC Form 4 filed by Gallagher Kathleen P.4 - Atrium Therapeutics, Inc. (0002093101) (Issuer)
- SEC Form 4 filed by Hoyos Rocio Martin4 - Atrium Therapeutics, Inc. (0002093101) (Issuer)
- SEC Form 4 filed by Younis Husam4 - Atrium Therapeutics, Inc. (0002093101) (Issuer)
- Chief Medical Officer Hughes Steven George sold $354,643 worth of shares (4,895 units at $72.45), decreasing direct ownership by 13% to 31,599 units (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- President and CEO Boyce Sarah sold $1,042,338 worth of shares (14,387 units at $72.45), decreasing direct ownership by 5% to 269,007 units (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- Chief Scientific Officer Flanagan W. Michael sold $473,388 worth of shares (6,534 units at $72.45), decreasing direct ownership by 7% to 85,093 units (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- Chief Financial Officer Maclean Michael F sold $329,068 worth of shares (4,542 units at $72.45), decreasing direct ownership by 7% to 59,290 units (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- Director Levin Arthur A sold $127,367 worth of shares (1,758 units at $72.45), decreasing direct ownership by 10% to 16,562 units (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- Chief Human Resources Officer Mccarthy Teresa sold $212,206 worth of shares (2,929 units at $72.45), decreasing direct ownership by 3% to 113,938 units (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- President and CEO Boyce Sarah sold $619,444 worth of shares (8,576 units at $72.23), decreasing direct ownership by 3% to 283,394 units (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- Chief Technical Officer Calderaro Charles Iii sold $269,201 worth of shares (3,727 units at $72.23), decreasing direct ownership by 7% to 49,797 units (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- Chief Legal Officer Moriarty John B sold $171,474 worth of shares (2,374 units at $72.23), decreasing direct ownership by 3% to 74,557 units (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- Chief Human Resources Officer Mccarthy Teresa sold $141,932 worth of shares (1,965 units at $72.23), decreasing direct ownership by 2% to 116,867 units (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- Chief Financial Officer Maclean Michael F sold $142,582 worth of shares (1,974 units at $72.23), decreasing direct ownership by 3% to 63,832 units (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- Chief Scientific Officer Flanagan W. Michael sold $171,402 worth of shares (2,373 units at $72.23), decreasing direct ownership by 3% to 91,627 units (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- Chief Medical Officer Hughes Steven George sold $171,402 worth of shares (2,373 units at $72.23), decreasing direct ownership by 6% to 36,494 units (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- Director Levin Arthur A gifted 1,330 shares, decreasing direct ownership by 7% to 18,320 units (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- Chief Technical Officer Calderaro Charles Iii was granted 23,250 shares and covered exercise/tax liability with 9,726 shares, increasing direct ownership by 34% to 53,524 units (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- Chief Scientific Officer Flanagan W. Michael was granted 27,500 shares and covered exercise/tax liability with 13,695 shares, increasing direct ownership by 17% to 94,000 units (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- Chief Commercial Officer Mosbrooker Eric covered exercise/tax liability with 47,990 shares and was granted 72,000 shares, increasing direct ownership by 44% to 79,010 units (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- President and CEO Boyce Sarah covered exercise/tax liability with 15,742 shares, gifted 29,159 shares and was granted 31,000 shares, decreasing direct ownership by 5% to 291,970 units (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- Chief Legal Officer Moriarty John B was granted 56,000 shares and covered exercise/tax liability with 26,824 shares, increasing direct ownership by 61% to 76,931 units (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- Chief Program Officer Gallagher Kathleen P. was granted 72,000 shares and covered exercise/tax liability with 41,366 shares, increasing direct ownership by 61% to 80,838 units (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- Chief Human Resources Officer Mccarthy Teresa was granted 39,000 shares and covered exercise/tax liability with 17,298 shares, increasing direct ownership by 22% to 118,832 units (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- Chief Medical Officer Hughes Steven George exercised 2,209 shares at a strike of $10.16 and sold $105,015 worth of shares (2,209 units at $47.54) (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- Chief Human Resources Officer Mccarthy Teresa exercised 20,000 shares at a strike of $22.34 and sold $1,003,058 worth of shares (20,000 units at $50.15) (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- Chief Commercial Officer Mosbrooker Eric exercised 6,562 shares at a strike of $9.05 and sold $297,771 worth of shares (6,562 units at $45.38) (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- Chief Medical Officer Hughes Steven George exercised 2,208 shares at a strike of $10.16 and sold $89,601 worth of shares (2,208 units at $40.58) (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- Chief Human Resources Officer Mccarthy Teresa exercised 15,000 shares at a strike of $22.34 and sold $621,142 worth of shares (15,000 units at $41.41) (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- Chief Medical Officer Hughes Steven George exercised 1,542 shares at a strike of $6.57 and sold $70,022 worth of shares (1,542 units at $45.41) (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- Chief Scientific Officer Flanagan W. Michael sold $778,702 worth of shares (20,000 units at $38.94) and exercised 20,000 shares at a strike of $14.22 (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- Director Wilson Troy Edward exercised 14,500 shares at a strike of $12.48 and sold $1,475,000 worth of shares (29,500 units at $50.00), decreasing direct ownership by 22% to 54,425 units (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- President and CEO Boyce Sarah exercised 50,000 shares at a strike of $1.24 and sold $2,497,435 worth of shares (50,000 units at $49.95) (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- Chief Commercial Officer Mosbrooker Eric exercised 6,563 shares at a strike of $9.05 and sold $308,936 worth of shares (6,563 units at $47.07) (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- Chief Program Officer Gallagher Kathleen P. sold $8,915 worth of shares (188 units at $47.42), decreasing direct ownership by 0.37% to 50,204 units (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- President and CEO Boyce Sarah exercised 25,000 shares at a strike of $1.24 and sold $1,234,700 worth of shares (25,000 units at $49.39) (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- Chief Medical Officer Hughes Steven George sold $102,462 worth of shares (2,208 units at $46.40) and exercised 2,208 shares at a strike of $10.16 (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- Chief Human Resources Officer Mccarthy Teresa exercised 10,000 shares at a strike of $22.34 and sold $465,632 worth of shares (10,000 units at $46.56) (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- Chief Financial Officer Maclean Michael F sold $1,320,844 worth of shares (30,914 units at $42.73), decreasing direct ownership by 32% to 65,806 units (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- Chief Medical Officer Hughes Steven George exercised 1,542 shares at a strike of $6.57 and sold $71,950 worth of shares (1,542 units at $46.66) (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- Chief Commercial Officer Mosbrooker Eric exercised 124,687 shares at a strike of $9.05 and sold $5,763,697 worth of shares (130,807 units at $44.06), decreasing direct ownership by 10% to 55,000 units (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- Director Wilson Troy Edward exercised 29,500 shares at a strike of $12.14 and sold $4,277,430 worth of shares (95,054 units at $45.00) (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- Director Levin Arthur A exercised 107,500 shares at a strike of $22.34 and sold $5,118,881 worth of shares (107,500 units at $47.62) (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- Chief Medical Officer Hughes Steven George exercised 47,451 shares at a strike of $12.21 and sold $3,480,269 worth of shares (81,434 units at $42.74), decreasing direct ownership by 47% to 38,867 units (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- Chief Legal Officer Moriarty John B sold $81,291 worth of shares (2,245 units at $36.21), decreasing direct ownership by 4% to 47,755 units (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- Chief Program Officer Gallagher Kathleen P. sold $27,549 worth of shares (911 units at $30.24), decreasing direct ownership by 2% to 50,392 units (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- Director Henig Noreen was granted 6,692 shares (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- Director Boess Carsten was granted 6,692 shares (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- Director Kaye Edward M. Md was granted 6,692 shares (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- Director Levin Arthur A was granted 6,692 shares, increasing direct ownership by 52% to 19,650 units (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- Director Skerjanec Simona was granted 6,692 shares (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- Director Wilson Troy Edward was granted 6,692 shares, increasing direct ownership by 11% to 69,425 units (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- Director Thompson Tamar was granted 6,692 shares (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- Director Kim Jean Jinsun was granted 6,692 shares (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- Chief Scientific Officer Flanagan W. Michael exercised 20,000 shares at a strike of $14.22 and sold $657,694 worth of shares (20,000 units at $32.88) (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- Chief Program Officer Gallagher Kathleen P. exercised 5,875 shares at a strike of $16.65 and sold $190,833 worth of shares (5,875 units at $32.48) (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
- Chief Program Officer Gallagher Kathleen P. exercised 5,875 shares at a strike of $16.65 and sold $190,324 worth of shares (5,875 units at $32.40) (SEC Form 4)4 - Avidity Biosciences, Inc. (0001599901) (Issuer)